SEARCH

SEARCH BY CITATION

References

  • Agrawal L., Louboutin J. P. and Strayer D. S. (2007) Preventing HIV-1 Tat-induced neuronal apoptosis using antioxidant enzymes: mechanistic and therapeutic implications. Virology 363, 462472.
  • Aksenov M. Y., Hasselrot U., Bansal A. K., Wu G., Nath A., Anderson C., Mactutus C. F. and Booze R. M. (2001) Oxidative damage induced by the injection of HIV-1 Tat protein in the rat striatum. Neurosci. Lett. 305, 58.
  • Aksenov M. Y., Aksenova M. V., Nath A., Ray P. D., Mactutus C. F. and Booze R. M. (2006) Cocaine-mediated enhancement of Tat toxicity in rat hippocampal cell cultures: the role of oxidative stress and D1 dopamine receptor. Neurotoxicology 27, 217228.
  • Ances B. M. and Ellis R. J. (2007) Dementia and neurocognitive disorders due to HIV-1 infection. Semin. Neurol. 27, 8692.
  • Banks W. A., Robinson S. M. and Nath A. (2005) Permeability of the blood-brain barrier to HIV-1 Tat. Exp. Neurol. 193, 218227.
  • Bonavia R., Bajetto A., Barbero S., Albini A., Noonan D. M. and Schettini G. (2001) HIV-1 Tat causes apoptotic death and calcium homeostasis alterations in rat neurons. Biochem. Biophys. Res. Commun. 288, 301308.
  • Bough K. J., Wetherington J., Hassel B., Pare J. F., Gawryluk J. W., Greene J. G., Shaw R., Smith Y., Geiger J. D. and Dingledine R. J. (2006) Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Ann. Neurol. 60, 223235.
  • Bouwman F. H., Skolasky R. L., Hes D., Selnes O. A., Glass J. D., Nance-Sproson T. E., Royal W., Dal Pan G. J. and McArthur J. C. (1998) Variable progression of HIV-associated dementia. Neurology 50, 18141820.
  • Buscemi L., Ramonet D. and Geiger J. D. (2007) Human immunodeficiency virus type-1 protein Tat induces tumor necrosis factor-alpha-mediated neurotoxicity. Neurobiol. Dis. 26, 661670.
  • Caporello E., Nath A., Slevin J., Galey D., Hamilton G., Williams L., Steiner J. P. and Haughey N. J. (2006) The immunophilin ligand GPI1046 protects neurons from the lethal effects of the HIV-1 proteins gp120 and Tat by modulating endoplasmic reticulum calcium load. J. Neurochem. 98, 146155.
  • Chandra T., Maier W., Konig H. G., Hirzel K., Kogel D., Schuler T., Chandra A., Demirhan I. and Laube B. (2005) Molecular interactions of the type 1 human immunodeficiency virus transregulatory protein Tat with N-methyl-d-aspartate receptor subunits. Neuroscience 134, 145153.
  • Chauhan A., Turchan J., Pocernich C., Bruce-Keller A., Roth S., Butterfield D. A., Major E. O. and Nath A. (2003) Intracellular human immunodeficiency virus Tat expression in astrocytes promotes astrocyte survival but induces potent neurotoxicity at distant sites via axonal transport. J. Biol. Chem. 278, 1351213519.
  • Cheng J., Nath A., Knudsen B., Hochman S., Geiger J. D., Ma M. and Magnuson D. S. (1998) Neuronal excitatory properties of human immunodeficiency virus type 1 Tat protein. Neuroscience 82, 97106.
  • Cheng B., Yang X., Hou Z., Lin X., Meng H., Li Z. and Liu S. (2007) D-beta-hydroxybutyrate inhibits the apoptosis of PC12 cells induced by 6-OHDA in relation to up-regulating the ratio of Bcl-2/Bax mRNA. Auton. Neurosci. 134, 3844.
  • Cheng B., Yang X., Chen C., Cheng D., Xu X. and Zhang X. (2010) D-beta-hydroxybutyrate prevents MPP+-induced neurotoxicity in PC12 cells. Neurochem. Res. 35, 444451.
  • Dong Z., Saikumar P., Weinberg J. M. and Venkatachalam M. A. (2006) Calcium in cell injury and death. Annu. Rev. Pathol. 1, 405434.
  • Ellis R. J., Gamst A. C., Capparelli E., Spector S. A., Hsia K., Wolfson T., Abramson I., Grant I. and McCutchan J. A. (2000) Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources. Neurology 54, 927936.
  • Ellis R. J., Rosario D., Clifford D. B. et al. (2010) Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study. Arch. Neurol. 67, 552558.
  • Eugenin E. A., D’Aversa T. G., Lopez L., Calderon T. M. and Berman J. W. (2003) MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis. J. Neurochem. 85, 12991311.
  • Eugenin E. A., King J. E., Nath A., Calderon T. M., Zukin R. S., Bennett M. V. and Berman J. W. (2007) HIV-tat induces formation of an LRP-PSD-95- NMDAR-nNOS complex that promotes apoptosis in neurons and astrocytes. Proc. Natl Acad. Sci. USA 104, 34383443.
  • Ferri K. F., Jacotot E., Blanco J., Este J. A. and Kroemer G. (2000) Mitochondrial control of cell death induced by HIV-1-encoded proteins. Ann. N. Y. Acad. Sci. 926, 149164.
  • Fotheringham J., Mayne M., Holden C., Nath A. and Geiger J. D. (2004) Adenosine receptors control HIV-1 Tat-induced inflammatory responses through protein phosphatase. Virology 327, 186195.
  • Freeman J. M., Vining E. P., Pillas D. J., Pyzik P. L., Casey J. C. and Kelly L. M. (1998) The efficacy of the ketogenic diet-1998: a prospective evaluation of intervention in 150 children. Pediatrics, 102, 13581363.
  • Gavriil E. S., Cooney R. and Weeks B. S. (2000) Tat mediates apoptosis in vivo in the rat central nervous system. Biochem. Biophys. Res. Commun. 267, 252256.
  • Ghafouri M., Amini S., Khalili K. and Sawaya B. E. (2006) HIV-1 associated dementia: symptoms and causes. Retrovirology 3, 28.
  • Haces M. L., Hernandez-Fonseca K., Medina-Campos O. N., Montiel T., Pedraza-Chaverri J. and Massieu L. (2008) Antioxidant capacity contributes to protection of ketone bodies against oxidative damage induced during hypoglycemic conditions. Exp. Neurol. 211, 8596.
  • Hammer D. F., Unverferth D. V., Kelley R. E., Harvan P. A. and Altschuld R. A. (1988) Extraction and measurement of myocardial nucleotides, nucleosides, and purine bases by high-performance liquid chromatography. Anal. Biochem. 169, 300305.
  • Haughey N. J. and Mattson M. P. (2002) Calcium dysregulation and neuronal apoptosis by the HIV-1 proteins Tat and gp120. J. Acquir. Immune Defic. Syndr. 31, S5561.
  • Haughey N. J., Holden C. P., Nath A. and Geiger J. D. (1999) Involvement of inositol 1,4,5-trisphosphate-regulated stores of intracellular calcium in calcium dysregulation and neuron cell death caused by HIV-1 protein tat. J. Neurochem. 73, 13631374.
  • Haughey N. J., Nath A., Mattson M. P., Slevin J. T. and Geiger J. D. (2001) HIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity. J. Neurochem. 78, 457467.
  • Heaton R. K., Clifford D. B., Franklin D. R. Jr et al. (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75, 20872096.
  • Kashiwaya Y., Sato K., Tsuchiya N., Thomas S., Fell D. A., Veech R. L. and Passonneau J. V. (1994) Control of glucose utilization in working perfused rat heart. J. Biol. Chem. 269, 2550225514.
  • Kashiwaya Y., Takeshima T., Mori N., Nakashima K., Clarke K. and Veech R. L. (2000) D-beta-hydroxybutyrate protects neurons in models of Alzheimer’s and Parkinson’s disease. Proc. Natl Acad. Sci. USA 97, 54405444.
  • Kim do Y. and Rho J. M. (2008) The ketogenic diet and epilepsy. Curr. Opin. Clin. Nutr. Metab. Care 11, 113120.
  • Kim do Y., Davis L. M., Sullivan P. G., Maalouf M., Simeone T. A., van Brederode J. and Rho J. M. (2007) Ketone bodies are protective against oxidative stress in neocortical neurons. J. Neurochem. 101, 13161326.
  • Kim do Y., Vallejo J. and Rho J. M. (2010) Ketones prevent synaptic dysfunction induced by mitochondrial respiratory complex inhibitors. J. Neurochem. 114, 130141.
  • Kim T. A., Avraham H. K., Koh Y. H., Jiang S., Park I. W. and Avraham S. (2003) HIV-1 Tat-mediated apoptosis in human brain microvascular endothelial cells. J. Immunol. 170, 26292637.
  • King J. E., Eugenin E. A., Buckner C. M. and Berman J. W. (2006) HIV tat and neurotoxicity. Microbes Infect. 8, 13471357.
  • Kraft-Terry S. D., Buch S. J., Fox H. S. and Gendelman H. E. (2009) A coat of many colors: neuroimmune crosstalk in human immunodeficiency virus infection. Neuron 64, 133145.
  • Kruman I. I, Nath A. and Mattson M. P. (1998) HIV-1 protein Tat induces apoptosis of hippocampal neurons by a mechanism involving caspase activation, calcium overload, and oxidative stress. Exp. Neurol. 154, 276288.
  • Laffel L. (1999) Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes. Diabetes Metab. Res. Rev. 15, 412426.
  • Langford D., Grigorian A., Hurford R., Adame A., Crews L. and Masliah E. (2004) The role of mitochondrial alterations in the combined toxic effects of human immunodeficiency virus Tat protein and methamphetamine on calbindin positive-neurons. J. Neurovirol. 10, 327337.
  • Levine A. J., Singer E. J. and Shapshak P. (2009) The role of host genetics in the susceptibility for HIV-associated neurocognitive disorders. AIDS Behav. 13, 118132.
  • Li W., Huang Y., Reid R., Steiner J., Malpica-Llanos T., Darden T. A., Shankar S. K., Mahadevan A., Satishchandra P. and Nath A. (2008) NMDA receptor activation by HIV-Tat protein is clade dependent. J. Neurosci. 28, 1219012198.
  • Lindl K. A., Marks D. R., Kolson D. L. and Jordan-Sciutto K. L. (2010) HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities. J. Neuroimmune Pharmacol. 5, 294309.
  • Lund T. M., Risa O., Sonnewald U., Schousboe A. and Waagepetersen H. S. (2009) Availability of neurotransmitter glutamate is diminished when beta-hydroxybutyrate replaces glucose in cultured neurons. J. Neurochem. 110, 8091.
  • Maalouf M., Sullivan P. G., Davis L., Kim D. Y. and Rho J. M. (2007) Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation. Neuroscience 145, 256264.
  • Maalouf M., Rho J. M. and Mattson M. P. (2009) The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Res. Rev. 59, 293315.
  • Magnuson D. S., Knudsen B. E., Geiger J. D., Brownstone R. M. and Nath A. (1995) Human immunodeficiency virus type 1 tat activates non-N-methyl-d-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann. Neurol. 37, 373380.
  • Maher P. and Davis J. B. (1996) The role of monoamine metabolism in oxidative glutamate toxicity. J. Neurosci. 16, 63946401.
  • Malik S., Khalique H., Buch S. and Seth P. (2011) A growth factor attenuates HIV-1 Tat and morphine induced damage to human neurons: implication in HIV/AIDS-drug abuse cases. PLoS ONE 6, e18116.
  • Maragos W. F., Young K. L., Turchan J. T., Guseva M., Pauly J. R., Nath A. and Cass W. A. (2002) Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function. J. Neurochem. 83, 955963.
  • Masino S. A., Li T., Theofilas P., Sandau U. S., Ruskin D. N., Fredholm B. B., Geiger J. D., Aronica E. and Boison D. (2011) A ketogenic diet suppresses seizures in mice through adenosine A receptors. J. Clin. Invest. 121, 26792683.
  • Massieu L., Haces M. L., Montiel T. and Hernandez-Fonseca K. (2003) Acetoacetate protects hippocampal neurons against glutamate-mediated neuronal damage during glycolysis inhibition. Neuroscience 120, 365378.
  • Mattson M. P., Chan S. L. and Duan W. (2002) Modification of brain aging and neurodegenerative disorders by genes, diet, and behavior. Physiol. Rev. 82, 637672.
  • Mattson M. P., Haughey N. J. and Nath A. (2005) Cell death in HIV dementia. Cell Death Differ. 12 Suppl 1, 893904.
  • Mayne M., Holden C. P., Nath A. and Geiger J. D. (2000) Release of calcium from inositol 1,4,5-trisphosphate receptor-regulated stores by HIV-1 Tat regulates TNF-alpha production in human macrophages. J. Immunol. 164, 65386542.
  • McArthur J. C. (2004) HIV dementia: an evolving disease. J. Neuroimmunol. 157, 310.
  • Menegon A., Leoni C., Benfenati F. and Valtorta F. (1997) Tat protein from HIV-1 activates MAP kinase in granular neurons and glial cells from rat cerebellum. Biochem. Biophys. Res. Commun. 238, 800805.
  • Merino J. J., Montes M. L., Blanco A. et al. (2011) [HIV-1 neuropathogenesis: therapeutic strategies against neuronal loss induced by gp120/Tat glycoprotein in the central nervous system]. Rev. Neurol. 52, 101111.
  • Milani D., Mazzoni M., Borgatti P., Zauli G., Cantley L. and Capitani S. (1996) Extracellular human immunodeficiency virus type-1 Tat protein activates phosphatidylinositol 3-kinase in PC12 neuronal cells. J. Biol. Chem. 271, 2296122964.
  • Mobbs C. V., Mastaitis J. W., Zhang M., Isoda F., Cheng H. and Yen K. (2007) Secrets of the lac operon. Glucose hysteresis as a mechanism in dietary restriction, aging and disease. Interdiscip. Top Gerontol. 35, 3968.
  • Morris A. A. (2005) Cerebral ketone body metabolism. J. Inherit. Metab. Dis. 28, 109121.
  • Nakazawa M., Kodama S. and Matsuo T. (1983) Effects of ketogenic diet on electroconvulsive threshold and brain contents of adenosine nucleotides. Brain Dev. 5, 375380.
  • Nath A. (2002) Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. J. Infect. Dis. 186(Suppl. 2), S193S198.
  • Nath A., Psooy K., Martin C., Knudsen B., Magnuson D. S., Haughey N. and Geiger J. D. (1996) Identification of a human immunodeficiency virus type 1 Tat epitope that is neuroexcitatory and neurotoxic. J. Virol. 70, 14751480.
  • Nath A., Haughey N. J., Jones M., Anderson C., Bell J. E. and Geiger J. D. (2000) Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine. Ann. Neurol. 47, 186194.
  • New D. R., Ma M., Epstein L. G., Nath A. and Gelbard H. A. (1997) Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron cultures. J. Neurovirol. 3, 168173.
  • Nicholls D. G. and Budd S. L. (2000) Mitochondria and neuronal survival. Physiol. Rev. 80, 315360.
  • Nicholls D. G., Johnson-Cadwell L., Vesce S., Jekabsons M. and Yadava N. (2007) Bioenergetics of mitochondria in cultured neurons and their role in glutamate excitotoxicity. J. Neurosci. Res. 85, 32063212.
  • Noh H. S., Hah Y. S., Nilufar R., Han J., Bong J. H., Kang S. S., Cho G. J. and Choi W. S. (2006) Acetoacetate protects neuronal cells from oxidative glutamate toxicity. J. Neurosci. Res. 83, 702709.
  • Norman J. P., Perry S. W., Kasischke K. A., Volsky D. J. and Gelbard H. A. (2007) HIV-1 trans activator of transcription protein elicits mitochondrial hyperpolarization and respiratory deficit, with dysregulation of complex IV and nicotinamide adenine dinucleotide homeostasis in cortical neurons. J. Immunol. 178, 869876.
  • Norman J. P., Perry S. W., Reynolds H. M. et al. (2008) HIV-1 Tat activates neuronal ryanodine receptors with rapid induction of the unfolded protein response and mitochondrial hyperpolarization. PLoS ONE 3, e3731.
  • Nuovo G. J., Becker J., Burk M. W., Margiotta M., Fuhrer J. and Steigbigel R. T. (1994) In situ detection of PCR-amplified HIV-1 nucleic acids in lymph nodes and peripheral blood in patients with asymptomatic HIV-1 infection and advanced-stage AIDS. J. Acquir. Immune Defic. Syndr. 7, 916923.
  • Perry S. W., Norman J. P., Litzburg A., Zhang D., Dewhurst S. and Gelbard H. A. (2005) HIV-1 transactivator of transcription protein induces mitochondrial hyperpolarization and synaptic stress leading to apoptosis. J. Immunol. 174, 43334344.
  • Pivovarova N. B., Nguyen H. V., Winters C. A., Brantner C. A., Smith C. L. and Andrews S. B. (2004) Excitotoxic calcium overload in a subpopulation of mitochondria triggers delayed death in hippocampal neurons. J. Neurosci. 24, 56115622.
  • Price T. O., Ercal N., Nakaoke R. and Banks W. A. (2005) HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells. Brain Res. 1045, 5763.
  • Rappaport J., Joseph J., Croul S., Alexander G., Del Valle L., Amini S. and Khalili K. (1999) Molecular pathway involved in HIV-1-induced CNS pathology: role of viral regulatory protein, Tat. J. Leukoc. Biol. 65, 458465.
  • Rizzuto R., Brini M., Murgia M. and Pozzan T. (1993) Microdomains with high Ca2+ close to IP3-sensitive channels that are sensed by neighboring mitochondria. Science 262, 744747.
  • Rumbaugh J., Turchan-Cholewo J., Galey D., St Hillaire C., Anderson C., Conant K. and Nath A. (2006) Interaction of HIV Tat and matrix metalloproteinase in HIV neuropathogenesis: a new host defense mechanism. FASEB J. 20, 17361738.
  • Rumbaugh J. A., Li G., Rothstein J. and Nath A. (2007) Ceftriaxone protects against the neurotoxicity of human immunodeficiency virus proteins. J. Neurovirol. 13, 168172.
  • Samartsev V. N. and Kozhina O. V. (2010) Acetoacetate as regulator of palmitic acid-induced uncoupling involving liver mitochondrial ADP/ATP antiporter and aspartate/glutamate antiporter. Biochemistry (Mosc) 75, 598605.
  • Sato K., Kashiwaya Y., Keon C. A., Tsuchiya N., King M. T., Radda G. K., Chance B., Clarke K. and Veech R. L. (1995) Insulin, ketone bodies, and mitochondrial energy transduction. FASEB J. 9, 651658.
  • Self R. L., Mulholland P. J., Harris B. R., Nath A. and Prendergast M. A. (2004a) Cytotoxic effects of exposure to the human immunodeficiency virus type 1 protein Tat in the hippocampus are enhanced by prior ethanol treatment. Alcohol. Clin. Exp. Res. 28, 19161924.
  • Self R. L., Mulholland P. J., Nath A., Harris B. R. and Prendergast M. A. (2004b) The human immunodeficiency virus type-1 transcription factor Tat produces elevations in intracellular Ca2+ that require function of an N-methyl-d-aspartate receptor polyamine-sensitive site. Brain Res. 995, 3945.
  • Shi B., Raina J., Lorenzo A., Busciglio J. and Gabuzda D. (1998) Neuronal apoptosis induced by HIV-1 Tat protein and TNF-alpha: potentiation of neurotoxicity mediated by oxidative stress and implications for HIV-1 dementia. J. Neurovirol. 4, 281290.
  • Singh I. N., El-Hage N., Campbell M. E., Lutz S. E., Knapp P. E., Nath A. and Hauser K. F. (2005) Differential involvement of p38 and JNK MAP kinases in HIV-1 Tat and gp120-induced apoptosis and neurite degeneration in striatal neurons. Neuroscience 135, 781790.
  • Song L., Nath A., Geiger J. D., Moore A. and Hochman S. (2003) Human immunodeficiency virus type 1 Tat protein directly activates neuronal N-methyl-D-aspartate receptors at an allosteric zinc-sensitive site. J. Neurovirol. 9, 399403.
  • Sullivan P. G., Rippy N. A., Dorenbos K., Concepcion R. C., Agarwal A. K. and Rho J. M. (2004) The ketogenic diet increases mitochondrial uncoupling protein levels and activity. Ann. Neurol. 55, 576580.
  • Suzuki M., Suzuki M., Sato K., Dohi S., Sato T., Matsuura A. and Hiraide A. (2001) Effect of beta-hydroxybutyrate, a cerebral function improving agent, on cerebral hypoxia, anoxia and ischemia in mice and rats. Jpn. J. Pharmacol. 87, 143150.
  • Thaler S., Choragiewicz T. J., Rejdak R., Fiedorowicz M., Turski W. A., Tulidowicz-Bielak M., Zrenner E., Schuettauf F. and Zarnowski T. (2010) Neuroprotection by acetoacetate and beta-hydroxybutyrate against NMDA-induced RGC damage in rat--possible involvement of kynurenic acid. Graefes Arch. Clin. Exp. Ophthalmol. 248, 17291735.
  • Tieu K., Perier C., Caspersen C. et al. (2003) D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease. J. Clin. Invest. 112, 892901.
  • Valdes J. J. and Weeks O. I. (2009) Estradiol and lithium chloride specifically alter NMDA receptor subunit NR1 mRNA and excitotoxicity in primary cultures. Brain Res. 1268, 112.
  • Veech R. L., Chance B., Kashiwaya Y., Lardy H. A. and Cahill G. F. Jr (2001) Ketone bodies, potential therapeutic uses. IUBMB Life 51, 241247.
  • Wallace D. R. (2006) HIV neurotoxicity: potential therapeutic interventions. J. Biomed. Biotechnol. 2006, 65741.
  • Wallace D. R., Dodson S. L., Nath A. and Booze R. M. (2006) Delta opioid agonists attenuate TAT(1-72)-induced oxidative stress in SK-N-SH cells. Neurotoxicology 27, 101107.
  • Westendorp M. O., Frank R., Ochsenbauer C., Stricker K., Dhein J., Walczak H., Debatin K. M. and Krammer P. H. (1995) Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375, 497500.
  • Xiao H., Neuveut C., Tiffany H. L., Benkirane M., Rich E. A., Murphy P. M. and Jeang K. T. (2000) Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1. Proc. Natl Acad. Sci. USA 97, 1146611471.
  • Xu J. and Ikezu T. (2009) The comorbidity of HIV-associated neurocognitive disorders and Alzheimer’s disease: a foreseeable medical challenge in post-HAART era. J. Neuroimmune Pharmacol. 4, 200212.
  • Zhu X., Yao H., Peng F., Callen S. and Buch S. (2009) PDGF-mediated protection of SH-SY5Y cells against Tat toxin involves regulation of extracellular glutamate and intracellular calcium. Toxicol. Appl. Pharmacol. 240, 286291.
  • Zou W., Kim B. O., Zhou B. Y., Liu Y., Messing A. and He J. J. (2007) Protection against human immunodeficiency virus type 1 Tat neurotoxicity by Ginkgo biloba extract EGb 761 involving glial fibrillary acidic protein. Am. J. Pathol. 171, 19231935.